Takeda, Lilly Fined $9B for Hiding Cancer Risks

A Louisiana federal court ordered Takeda Pharmaceutical Co. and Eli Lilly & Co. to pay a combined $9 billion in punitive damages after a jury found they covered up the cancer risks of their Actos diabetes drug.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news